Showing results (4281-4290 of 10,388) with videos related to
Sort By:
Pageof 1,039
Vaccines|July 27, 2022
Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMARenzo Alfini, Brunella Brunelli, Erika Bartolini, et al.Vaccines|July 27, 2022
Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya-Findings and ImplicationsChester O Kolek, Sylvia A Opanga, Faith Okalebo, et al.Vaccines|July 27, 2022
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel DiseasesKeren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, et al.Vaccines|July 27, 2022
HPV-Vaccine Hesitancy in Colombia: A Mixed-Methods StudyVeronica Cordoba-Sanchez, Mariantonia Lemos, Diego Alfredo Tamayo-Lopera, et al.Vaccines|January 26, 2016
Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7Bassel Akache, Risini D Weeratna, Aparna Deora, et al.Vaccines|October 27, 2015
A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein AMarco Tamborrini, Nina Geib, Aniebrys Marrero-Nodarse, et al.Vaccines|October 13, 2015
Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine PlatformPavimol Angsantikul, Soracha Thamphiwatana, Weiwei Gao, et al.Vaccines|October 17, 2015
Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and DiseasePatricia A Jorquera, Katie E Oakley, Thomas J Powell, et al.Vaccines|September 8, 2015
Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical TestingArthur M Dannenberg, Bappaditya DeyVaccines|September 8, 2015
Tumor-Associated Glycans and Immune SurveillanceBehjatolah Monzavi-Karbassi, Anastas Pashov, Thomas Kieber-EmmonsPageof 1,039